B-cell activation influences T-cell polarization and outcome of anti-CD20 B-cell depletion in central nervous system autoimmunity - Wikidata - awgldk - TriplyDB

B-cell activation influences T-cell polarization and outcome of anti-CD20 B-cell depletion in central nervous system autoimmunity

B-cell activation influences T-cell polarization and outcome of anti-CD20 B-cell depletion in central nervous system autoimmunity

http://www.wikidata.org/entity/Q36034499

about

Multiple sclerosis, relapses, and the mechanism of action of adrenocorticotropic hormone B Cells Are Multifunctional Players in Multiple Sclerosis Pathogenesis: Insights from Therapeutic Interventions CD8(+) T-Cells as Immune Regulators of Multiple Sclerosis Hypersensitivity Responses in the Central Nervous System Novel Insights and Therapeutics in Multiple Sclerosis Inebilizumab, a B Cell-Depleting Anti-CD19 Antibody for the Treatment of Autoimmune Neurological Diseases: Insights from Preclinical Studies Glatiramer acetate in the treatment of multiple sclerosis: emerging concepts regarding its mechanism of action Therapeutic decisions in multiple sclerosis: moving beyond efficacy Rituximab therapy reduces organ-specific T cell responses and ameliorates experimental autoimmune encephalomyelitis.Rituximab efficiently depletes increased CD20-expressing T cells in multiple sclerosis patients.Utility and safety of rituximab in pediatric autoimmune and inflammatory CNS disease.Developmental maturation of innate immune cell function correlates with susceptibility to central nervous system autoimmunity.Neuroantigen-specific autoregulatory CD8+ T cells inhibit autoimmune demyelination through modulation of dendritic cell function.Accelerated central nervous system autoimmunity in BAFF-receptor-deficient mice Comparative study on the therapeutic potential of neurally differentiated stem cells in a mouse model of multiple sclerosis.Intrathecal anti-CD20 efficiently depletes meningeal B cells in CNS autoimmunity.The contribution of immune and glial cell types in experimental autoimmune encephalomyelitis and multiple sclerosis Passive experimental autoimmune encephalomyelitis in C57BL/6 with MOG: evidence of involvement of B cells.Interleukin 6 signaling promotes anti-aquaporin 4 autoantibody production from plasmablasts in neuromyelitis optica.Limited sufficiency of antigen presentation by dendritic cells in models of central nervous system autoimmunity.IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases.Dynamic cross-regulation of antigen-specific effector and regulatory T cell subpopulations and microglia in brain autoimmunity.Proinflammatory role of aquaporin-4 in autoimmune neuroinflammation.The role of B cells and humoral immunity in Mycobacterium tuberculosis infection Nogo-receptor 1 deficiency has no influence on immune cell repertoire or function during experimental autoimmune encephalomyelitis.Is intrathecal anti-CD20 an option to target compartmentalized CNS inflammation in progressive MS?Uptake and presentation of myelin basic protein by normal human B cells.Update on the autoimmune pathology of multiple sclerosis: B-cells as disease-drivers and therapeutic targets B-cell very late antigen-4 deficiency reduces leukocyte recruitment and susceptibility to central nervous system autoimmunity.Anti-CD20 B-cell depletion enhances monocyte reactivity in neuroimmunological disorders.B cell antigen presentation is sufficient to drive neuroinflammation in an animal model of multiple sclerosis.B cell depletion enhances T regulatory cell activity essential in the suppression of arthritis.Blood B Cell and Regulatory Subset Content in Multiple Sclerosis Patients.The Charcot Lecture | beating MS: a story of B cells, with twists and turns Aquaporin 4-specific T cells in neuromyelitis optica exhibit a Th17 bias and recognize Clostridium ABC transporter The Role of Latently Infected B Cells in CNS Autoimmunity.IgG glycan hydrolysis by EndoS inhibits experimental autoimmune encephalomyelitis B cell exchange across the blood-brain barrier in multiple sclerosis.CNS accumulation of regulatory B cells is VLA-4-dependent.Targeting B cells in the treatment of multiple sclerosis: recent advances and remaining challenges.

P2860

Q21558407-225A5A67-F5BA-42A5-832E-C26480538628 Q26770664-1A251647-377C-483B-A2D9-D79B1D026A68 Q26772339-1458EA5F-CB67-4396-8E95-583157C5FDD4 Q26779177-7264B2B4-C2FD-4C1D-A746-64376C36C035 Q26784619-9A8D3661-3D1C-480C-B5FC-E115A1E6C03E Q28067334-F831248E-5A67-4E64-901B-E0AE19DA1950 Q28308287-05082338-17E1-4C31-AAEF-38EF0286B7B8 Q28541039-C93F5BE3-A0DB-4427-8A49-91DEB5FF51A7 Q33832088-F558AEB5-1322-4CF2-9322-35EEA8D16C96 Q33849373-500412A2-C9DB-4F14-AECA-906F1B4657AA Q33980153-CD508F4C-9811-4549-B577-B0387E3A765C Q34061505-6E700DFB-0871-49B5-B474-3D4F187EF2FA Q34075707-409BAE17-F510-4344-B01A-B0BF08202DE0 Q34231528-3B9B0BB3-F862-429B-9E01-7505BBF590C7 Q34238869-7E9B2EC5-E938-4BB8-A69C-C6BD095C1916 Q34287001-639F51CD-E2B9-4430-9501-4909F4A167CD Q34413247-1517DF07-30B1-4727-8029-2CF2806D4463 Q34540602-84356931-8645-4C72-8C55-0BF1969F8F0F Q34621516-CEEBB939-4F9A-4EF2-A577-05ED56BE1DA1 Q34645411-063ED86E-0118-4CAB-B38C-36C9C57553C8 Q34658996-23EB43AE-B106-45F7-9506-CF896D275A07 Q34687561-2A23F2A9-39D4-4695-82CE-9E788CF81543 Q34813295-840EEE67-549B-4E0D-980D-6709C6DD14A8 Q35039807-F763E8CF-41C4-4C9E-A301-9DF63F1D7139 Q35067696-72E2C82F-88BA-4DC7-A0FC-EEABE02396F9 Q35179828-EC23E9A6-5FC3-4B30-92CC-E9F238199938 Q35424431-CF79EF79-D3E5-42C2-94B9-1C3EF80E852C Q35463552-7EFB32B2-8C7C-4EC8-A008-3830622422B6 Q35514450-83E0FDE1-8C84-40CD-82CB-E4715693F2C0 Q35544312-36290FA7-5E3B-41C7-A458-3BBE5297C007 Q35613006-5293843C-31DA-48D3-B47F-284523B470BB Q35623403-E0BC5C13-DFAE-4162-8826-29B7F005E29B Q35794278-ED991071-38EC-4584-A313-11693F2178CC Q36086475-E8387A50-44AD-4FBA-8EEA-C29CD2D8DB95 Q36117107-0AE98DE9-7D2A-4A7E-B5FC-1155572D6E64 Q36216025-03D34034-D4A4-4847-B507-A20D95B7A756 Q36281698-9877FE34-B1A8-429E-AC9B-3AE577C7FD8E Q36498036-CBFCF32A-0891-43A1-98B9-69AC3A1CCAAC Q36694494-E9D724B1-A529-4A3A-B247-7D2EC9B1A0E5 Q36761844-171596E1-728C-4162-9DDD-E88B02FA3504

P2860

B-cell activation influences T-cell polarization and outcome of anti-CD20 B-cell depletion in central nervous system autoimmunity

http://www.wikidata.org/entity/Q36034499

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

2010年论文

@zh

2010年论文

@zh-cn

name

B-cell activation influences T ...... al nervous system autoimmunity

@ast

B-cell activation influences T ...... al nervous system autoimmunity

@en

type

label

B-cell activation influences T ...... al nervous system autoimmunity

@ast

B-cell activation influences T ...... al nervous system autoimmunity

@en

prefLabel

B-cell activation influences T ...... al nervous system autoimmunity

@ast

B-cell activation influences T ...... al nervous system autoimmunity

@en

P1433

Q36034499-9B1DE28E-8D47-4814-91E0-9B786E17DFF7

P1476

Q36034499-36A10969-F95D-413A-937F-B96E31645EC5

P2093

Q36034499-05D8B87F-5003-4614-ACF8-EA398E85A5F1

Q36034499-50305DAC-FBF1-47A0-9989-B58B0BF33DC6

Q36034499-541AB154-FB87-4911-B131-AF0BBE28A205

Q36034499-568480A5-479B-4CB5-A81A-25A28DFB5596

Q36034499-67ECB8BC-4E4A-4B32-B15B-93B411401C95

Q36034499-A27A05EE-BEB2-4EB8-8D82-7FDF86B050A3

Q36034499-C0325883-3B7F-47A2-B87F-C7174E2F195E

Q36034499-C6D980F1-B860-468E-85C8-2DC21B4B3970

Q36034499-DFF9741D-599E-4E3E-9933-2B69E4F60A3B

P2860

Q36034499-031A3392-A4F5-4DFF-B353-B81A43A4549E

Q36034499-05F6A3D4-904A-4B8A-B7DE-3EA5CA849381

Q36034499-096DD17D-8A55-420C-9F5E-0F07857158A9

Q36034499-0D102AA4-615C-4AC3-B0C6-FB0415935E17

Q36034499-176055A7-5103-4F3A-9CF8-EE5B2307A44F

Q36034499-22F4EE44-C121-4170-9FE9-0413BF8832EA

Q36034499-2367E548-B2F1-495A-B356-14753B5DEF36

Q36034499-23F99015-1480-4FF5-B038-BF9DD2921366

Q36034499-24D62370-71E9-447A-8967-EF26D70DC656

Q36034499-24FF6A40-39D9-4AB3-8609-498978683BCE

P304

Q36034499-CB49BD1E-3D40-417A-BDAE-850F9DE16366

P31

Q36034499-4F75CF93-CA5B-47C2-9BE2-749BB8F221FD

P356

Q36034499-EA8DBB62-FC10-4D67-8404-D07542085696

P433

Q36034499-EB9C33C0-B4E9-464D-A5F7-6BCE092EC59F

P478

Q36034499-820BEE51-7680-4B11-872C-F08E44F14158

P50

Q36034499-0B85A920-F8F0-4172-B9C9-4A81EE98FA93

Q36034499-1EE93966-6F22-4018-8D50-1779E84EB6BB

Q36034499-4AB59EAD-826F-4C9E-85AA-8C34E97253CA

Q36034499-D98A2AAE-E036-4F8D-B7E9-9D9142EE43E3

P577

Q36034499-A3F93264-6BA2-40E3-9F95-662CE8AD4974

P5875

Q36034499-5BFB72F8-9529-4BD1-B2E0-98B8A997E844

P698

Q36034499-CD9B27B8-D39B-465A-8941-A0E10E1EE829

P932

Q36034499-8914725E-327B-4323-BD7D-EF6C3DBE41ED

P356

P1433

Annals of Neurology

P1476

B-cell activation influences T ...... al nervous system autoimmunity

@en

P2093

Anthony J Slavin

http://www.w3.org/2001/XMLSchema#string

Flavius Martin

http://www.w3.org/2001/XMLSchema#string

Juan C Patarroyo

http://www.w3.org/2001/XMLSchema#string

Klaus Lehmann-Horn

http://www.w3.org/2001/XMLSchema#string

Martin S Weber

http://www.w3.org/2001/XMLSchema#string

Nicolas Molnarfi

http://www.w3.org/2001/XMLSchema#string

Scott S Zamvil

http://www.w3.org/2001/XMLSchema#string

Tara Karnezis

http://www.w3.org/2001/XMLSchema#string

Thomas Prod'homme

http://www.w3.org/2001/XMLSchema#string

P2860

The crystal structure of myelin oligodendrocyte glycoprotein, a key autoantigen in multiple sclerosis

B-cell depletion with rituximab in relapsing-remitting multiple sclerosis

Multiple immuno-regulatory defects in type-1 diabetes

Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination

Induction of CD4+CD25+ regulatory T cells by copolymer-I through activation of transcription factor Foxp3

Pathogenic myelin oligodendrocyte glycoprotein antibodies recognize glycosylated epitopes and perturb oligodendrocyte physiology

B cells regulate autoimmunity by provision of IL-10.

Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis.

Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis.

Novel suppressive function of transitional 2 B cells in experimental arthritis.

P304

369-383

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/ANA.22081

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

68

http://www.w3.org/2001/XMLSchema#string

P50

Christopher Linington

Dimitry M Danilenko

Claude C A Bernard

Jeffrey Eastham-Anderson

P577

2010-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

45273143

http://www.w3.org/2001/XMLSchema#string

P698

20641064

http://www.w3.org/2001/XMLSchema#string

P932

3375897

http://www.w3.org/2001/XMLSchema#string